The Latest News
Awards & Recognitions
Dr. Susan L. Freeman will become Rush University’s provost and senior vice president, beginning Oct 1. Freeman will serve as the University’s chief operating officer responsible for coordinating and overseeing the implementation of the University strategic plan and advancing its population health equity mission.
Community, Patient Care
Rush University Medical Center has joined the national movement to improve health care for older adults by becoming the only hospital in Illinois to be part of the Age-Friendly Health Systems initiative.
Alumni
Rush University Medical Center has renamed its orthopedic building the Sofija and Jorge O. Galante Orthopedic Building in recognition of Dr. Jorge Galante’s leadership, his revolutionary contributions to his field and the Galante family’s lasting legacy of philanthropy.
Student Stories, Alumni, Research, Rush Medical College
Jennillee Wallace always knew she wanted to pursue science. After completing two advanced degree programs, she’s now a researcher at Rush.
Careers, College of Health Sciences
Medical laboratory scientists play a vital role in patient care while utilizing leading-edge technology. See what medical laboratory science careers await you!
Research
The National Institute on Drug Abuse recently awarded Rush a $2 million grant to establish a research center to improve the delivery of scientifically based treatments to substance misuse patients.
Patient Care, College of Nursing
Erik McIntosh, a Rush University Medical Center nurse practitioner, is working to improve health care for LGBTQ patients.
Research
Rush University Medical Center researchers have proposed a one-to-10 rating system that standardizes and combines scoring data from five leading hospital rating systems into an easy-to-understand composite score that will help guide consumer hospitals choice.
College of Health Sciences
As the field has expanded exponentially, the master’s program in the College of Health Sciences prepares today’s students for critical roles in health care.
Research
Findings published today in the journal Science Translational Medicine suggest that a type of white blood cell called tumor associated macrophages that have been deceived by pancreatic cancer cells into not attacking them can be “reprogrammed” by a specially designed molecule that activates a protein found on their surfaces.
